A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc…
Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
19
Aug |
Optical Coherence Tomography Shows Promise As Future Pancreatic Cancer Diagnostic ToolCategory: Pancreatic Cancer | Leave a Comment |
A team of researchers from four Boston-area institutions led by Nicusor Iftimia from Physical Sciences, Inc…
|
5
May |
Boston Scientific’s SpyGlass® Direct Visualization System Achieves Global Utilization MilestonesCategory: Pancreatic Cancer | Leave a Comment |
Boston Scientific Corporation (NYSE: BSX) announced several milestones in the adoption of its SpyGlass® Direct Visualization System since its worldwide launch in July 2007. The SpyGlass System guides visualization and accessory devices for diagnostic and therapeutic procedures in the pancreatico-biliary system, including the hepatic ducts…
|
19
Nov |
Robotic-Assisted Surgery Appears Safe For Complicated Pancreatic ProceduresCategory: Pancreatic Cancer | Leave a Comment |
A study involving 30 patients suggests that robotic-assisted surgery involving complex pancreatic procedures can be performed safely in a high-volume facility, according to a report posted online today that will be published in the March print issue of Archives of Surgery, one of the JAMA/Archives journals…
|
28
Oct |
Deadly Pancreatic Cancer Develops Much More Slowly Than We Thought, Raising Hopes Of Earlier DetectionCategory: Pancreatic Cancer | Leave a Comment |
Scientists who studied the genetics of pancreatic cancer, one of the deadliest cancers with fewer than five per cent of patients still alive five years after diagnosis, found that it takes much longer to grow than we thought, as long as 20 years to become lethal, but the good news is this extends the window of opportunity for earlier detection, especially if a blood o…
|
5
Mar |
First Use Of Innovative “IRE” On Pancreatic TumorCategory: Pancreatic Cancer | Leave a Comment |
A new procedure for treating pancreatic and liver cancers using electrical fields to poke holes in tumors was used for the first time anywhere to fight pancreatic cancer at Stony Brook University Medical Center by Kevin Watkins, M.D., Chief of the Upper Gastrointestinal and General Oncologic Surgery Group…
|
20
Apr |
Newly Discovered Epidermal Growth Factor Receptor Active In Human Pancreatic CancersCategory: Pancreatic Cancer | Leave a Comment |
Finally some promising news about pancreatic cancer, one of the most fatal cancers, due to the difficulties of early detection and the lack of effective therapies: Johns Hopkins University pathologist Akhilesh Pandey has identified an epidermal growth factor receptor aberrantly active in approximately a third of the 250 human pancreatic cancers studied. In a presentation April 18, at Experimental Biology 2009 in New Orleans, Dr.
|
7
Apr |
Strategic Approach To Early-Detection Of Pancreatic Cancer BiomarkersCategory: Pancreatic Cancer | Leave a Comment |
A cancer scientist from Johns Hopkins has convinced an international group of colleagues to delay their race to find new cancer biomarkers and instead begin a 7,000-hour slog through a compendium of 50,000 scientific articles already published to assemble, decode and analyze the molecules that might herald the furtive presence of pancreatic cancer.
|
3
Apr |
Surgeon Performs The World’s First Successful ViKY Robot Assisted Surgery To Treat Pancreatic TumorsCategory: Pancreatic Cancer | Leave a Comment |
Fox Chase Cancer Center performed the world’s first successful minimally invasive distal pancreatectomy using the ViKY® system’s revolutionary robotic, compact laparoscope holder. The technology, developed in France and tested on thousands of patients in Europe, made its debut in a cancer setting in the United States at Fox Chase.